Figure 1From: DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists Mean cumulative change in HAQ from starting therapy in patients with rheumatoid arthritis following cycling between TNF antagonists. Back to article page